Cochlear Limited (CHEOF)
Cochlear Limited operates in the Medical - Devices industry of the Healthcare sector, headquartered in Sydney, NSW, AU. The stock last traded at $91.91, up 4.28% on the session, giving a market capitalisation of $6.01B. On trailing twelve-month figures it carries a trailing P/E of 24.94, a net margin of 14.6%. Its beta of 0.26 implies it has historically moved less than the broad market.
Cochlear Limited is an Australian enterprise, established in Sydney in 1981, that specializes in advanced implantable hearing technology. This global company develops and distributes a range of auditory solutions for both pediatric and adult populations worldwide. Its product lineup includes cochlear implant devices, upgrades for sound processors, bone conduction systems, and a variety of associated accessories.
Cochlear Limited is most often compared with the following Healthcare names: